We are live on ! Find out more
ENTL

Entellus Medical, Inc. Common Stock
ENTL

Delisted

ENTL was delisted on the 27th of February, 2018.

Back to rankings

73 hedge funds and large institutions have $301M invested in Entellus Medical, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 40 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 12

36% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 11

29% more capital invested

Capital invested by funds: $234M → $301M (+$67.7M)

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

6% more funds holding

Funds holding: 69 → 73 (+4)

Holders
73
Holders Change
+4
Holders Change %
+5.8%
% of All Funds
1.82%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.12%
New
15
Increased
40
Reduced
12
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$12.4M
2
FCM
Frontier Capital Management
Massachusetts
+$5.54M
3
TCM
Tekla Capital Management
Massachusetts
+$4.75M
4
DGI
Discovery Group I
Illinois
+$3.25M
5
NC
Nicholas Company
Wisconsin
+$3.15M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$16.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.86M
3
KCM
Kingdon Capital Management
New York
-$4.53M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$1.76M
5
LCM
Laurion Capital Management
New York
-$1.71M

ENTL Hedge Fund Activity: Q2 2017 in Review

73 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Entellus Medical, Inc. Common Stock (ENTL) for Q2 2017, worth a combined $301M — up 29% from $234M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ENTL positions and 11 closed out — a net gain of 4 holders — while 40 added to existing stakes and 12 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $12.4M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $16.4M sold.

  • 73 institutional investors held Entellus Medical, Inc. Common Stock (ENTL) as of Q2 2017, up from 69 in Q1 2017.
  • Funds reported $301M of Entellus Medical, Inc. Common Stock stock for Q2 2017, up 29% quarter-over-quarter.
  • 15 funds opened new Entellus Medical, Inc. Common Stock positions in Q2 2017 and 11 closed out, a net change of +4 holders.
  • The largest Entellus Medical, Inc. Common Stock buyer in Q2 2017 was Adage Capital Partners, an estimated $12.4M added.
  • The largest Entellus Medical, Inc. Common Stock seller in Q2 2017 was T. Rowe Price Associates, an estimated $16.4M sold.

Based on aggregated 13F filings for Q2 2017.